STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - GROSSSocial Capital Suvretta Holdings Corp. I • April 4th, 2022 • Surgical & medical instruments & apparatus
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • April 4th, 2022 • Social Capital Suvretta Holdings Corp. I • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of May 25, 2021 (the “Effective Date”) among (a) SILICON VALLEY BANK, a California corporation (“SVB”), in its capacity as administrative agent and collateral agent (“Agent”), (b) SILICON VALLEY BANK, a California corporation, as a lender, (c) SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership (“SVB Innovation Fund”), as a lender (SVB and SVB Innovation Fund and each of the other “Lenders” from time to time a party hereto are referred to herein collectively as the “Lenders” and each individually as a “Lender”), and (d) AKILI INTERACTIVE LABS, INC., a Delaware corporation (“Borrower”), provides the terms on which Agent and the Lenders shall lend to Borrower, and Borrower shall repay Agent and the Lenders.
LEASELease • April 4th, 2022 • Social Capital Suvretta Holdings Corp. I • Surgical & medical instruments & apparatus • Massachusetts
THIS INSTRUMENT IS AN INDENTURE OF LEASE in which the Landlord and the Tenant are the patties hereinafter named, and which relates to space in the building known as and numbered as 123-125 Broad Street, Boston, Massachusetts (the “Building”), which Building is situated on a certain parcel of land containing approximately 3,975+/-square feet.
OPTION AND COLLABORATION AGREEMENTOption and Collaboration Agreement • April 4th, 2022 • Social Capital Suvretta Holdings Corp. I • Surgical & medical instruments & apparatus • New York
This OPTION AND COLLABORATION AGREEMENT (this “Agreement”), dated as of December 19, 2018 (the “Effective Date”), is entered into by and between Akili Interactive Labs, Inc., a Delaware corporation having its principal place of business at 125 Broad Street, 4th Floor, Boston, MA 02110, U.S.A., (“Akili”), and Shionogi & Co., Ltd., a company organized under the laws of Japan having its principal place of business at 1 -8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, Japan (“Shionogi”). Akili and Shionogi are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
CERTAIN CONFIDENTIAL INFORMATION, MARKED BY [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTLicense, Development and Commercialization Agreement • April 4th, 2022 • Social Capital Suvretta Holdings Corp. I • Surgical & medical instruments & apparatus • New York
This LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is made as of 16 August 2021 (the “Effective Date”) by and between Akili Interactive Labs, Inc. with a place of business at 125 Broad Street, 5th Floor, Boston, MA 02110 (“Akili”) and TALi Digital Limited with a place of business at Level 5, 19 William Street, Cremorne Victoria 3121 Australia (“TALi”). Akili and TALi are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
Scientific Advisory Board and Chief Science Advisor AgreementBoard and Chief Science Advisor Agreement • April 4th, 2022 • Social Capital Suvretta Holdings Corp. I • Surgical & medical instruments & apparatus • California
This SCIENTIFIC ADVISORY BOARD AND CHIEF SCIENCE ADVISOR AGREEMENT (“Agreement”), made this 1st day of May, 2016 (the “Effective Date”), is entered into by Akili Interactive Labs, Inc., a Delaware company (“Akili”), and Adam Gazzaley (“Advisor”).
